QRD
The Pfizer jab is fully FDA approved and IS NOT still only under EUA. It has EUA for use as a third (booster) shot, and for children between ages 12-15. There is some confusion about the reference to the approved BLA in the EUA revision dated August 23, 2021.
The Full Run-Down
What is Comirnaty?
It is the same shot as Pfizer-BioNTech with a different name. The Pfizer shot has the active ingredient BNT162b2. This is the same active ingredient in Comirnaty.
For all intents and purposes, Pfizer-BioNTech and Comirnaty are interchangeable.
What is FDA approved?
The active component in the Pfizer mRNA shot (BNT162b2) has been fully FDA approved and marketed under the name Comirnaty:
COMIRNATY® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech.
- It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older
What did the August 12, 2021 EUA authorize?
The jab as a third (booster) shot and for children aged 12-15.
The authorizations for these vaccines have been amended to allow for an additional, or third, dose to be administered at least 28 days following the two-dose regimen of the same vaccine to individuals 18 years of age or older (ages 12 or older for Pfizer-BioNTech) who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.
What did the August 23, 2021 EUA revision authorize?
It added Comirnaty (the FDA approved jab) as a third (booster) shot and for children aged 12-15.
- It is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:
- prevent COVID-19 in individuals 12 through 15 years, and
- provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise
QRD
The Pfizer jab is fully FDA approved and IS NOT still only under EUA. It has EUA for use as a third (booster) shot, and for children between ages 12-15. There is some confusion about the reference to the approved BLA in the EUA revision dated August 23, 2021.
The Full Run-Down
What is Comirnaty?
It is the same shot as Pfizer-BioNTech with a different name. The Pfizer shot has the active ingredient BNT162b2. This is the same active ingredient in Comirnaty.
For all intents and purposes, Pfizer-BioNTech and Comirnaty are interchangeable.
What is FDA approved?
The active component in the Pfizer mRNA shot (BNT162b2) has been fully FDA approved and marketed under the name Comirnaty:
COMIRNATY® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech.
- It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older
What did the August 12, 2021 EUA authorize?
The jab as a third (booster) shot and for children aged 12-15.
The authorizations for these vaccines have been amended to allow for an additional, or third, dose to be administered at least 28 days following the two-dose regimen of the same vaccine to individuals 18 years of age or older (ages 12 or older for Pfizer-BioNTech) who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.
What did the August 23, 2021 EUA revision authorize?
It added Comirnaty (the FDA approved jab) as a third (booster) shot and for children aged 12-15.
- It is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:
- prevent COVID-19 in individuals 12 through 15 years, and
- provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise
QRD
The Pfizer jab is fully FDA approved and IS NOT still only under EUA. It has EUA for use as a third (booster) shot, and for children between ages 12-15. There is some confusion about the reference to the approved BLA in the EUA revision dated August 23, 2021.
The Full Run-Down
What is Comirnaty?
It is the same shot as Pfizer-BioNTech with a different name. The Pfizer shot has the active ingredient BNT162b2. This is the same active ingredient in Comirnaty.
For all intents and purposes, Pfizer-BioNTech and Comirnaty are interchangeable.
What is FDA approved?
The active component in the Pfizer mRNA shot (BNT162b2) has been fully FDA approved and marketed under the name Comirnaty:
COMIRNATY® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech.
- It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older
What did the August 12, 2021 EUA authorize?
The jab as a third (booster) shot and for children aged 12-15.
The authorizations for these vaccines have been amended to allow for an additional, or third, dose to be administered at least 28 days following the two-dose regimen of the same vaccine to individuals 18 years of age or older (ages 12 or older for Pfizer-BioNTech) who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.
What did the August 23, 2021 EUA revision authorize?
It added Comirnaty (the FDA approved jab) as a third (booster) shot and for children aged 12-15.
- It is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:
- prevent COVID-19 in individuals 12 through 15 years, and
- provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise
QRD
The Pfizer jab is fully FDA approved and IS NOT still only under EUA. It has EUA for use as a third (booster) shot, and for children between ages 12-15. There is some confusion about the reference to the approved BLA in the EUA revision dated August 23, 2021.
The Full Run-Down
What is Comirnaty?
It is the same shot as Pfizer-BioNTech with a different name. The Pfizer shot has the active ingredient BNT162b2. This is the same active ingredient in Comirnaty.
For all intents and purposes, Pfizer-BioNTech and Comirnaty are interchangeable.
What is FDA approved?
The active component in the Pfizer mRNA shot (BNT162b2) has been fully FDA approved and marketed under the name Comirnaty:
COMIRNATY® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech.
- It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older
What did the August 12, 2021 EUA authorize?
The authorizations for these vaccines have been amended to allow for an additional, or third, dose to be administered at least 28 days following the two-dose regimen of the same vaccine to individuals 18 years of age or older (ages 12 or older for Pfizer-BioNTech) who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.
What did the August 23, 2021 EUA revision authorize?
- It is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:
- prevent COVID-19 in individuals 12 through 15 years, and
- provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise
QRD
The Pfizer jab is fully FDA approved and IS NOT still only under EUA. It has EUA for use as a third (booster) shot, and for children between ages 12-15. There is some confusion about the reference to the approved BLA in the EUA revision dated August 23, 2021.
The Full Run-Down
What is Comirnaty?
It is the same shot as Pfizer-BioNTech with a different name. The Pfizer shot has the active ingredient BNT162b2. This is the same active ingredient in Comirnaty.
For all intents and purposes, Pfizer-BioNTech and Comirnaty are interchangeable.
What is FDA approved?
The active component in the Pfizer (BNT162b2) has been fully FDA approved and marketed under the name Comirnaty:
COMIRNATY® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech.
- It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older
What did the August 12, 2021 EUA authorize?
The authorizations for these vaccines have been amended to allow for an additional, or third, dose to be administered at least 28 days following the two-dose regimen of the same vaccine to individuals 18 years of age or older (ages 12 or older for Pfizer-BioNTech) who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.
What did the August 23, 2021 EUA revision authorize?
- It is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:
- prevent COVID-19 in individuals 12 through 15 years, and
- provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise